A prospective (partially retrospective) observational study to assess the burden of severe rotavirus gastroenteritis (RVGE) in four pediatric clinics and one hospital in Shibata-City, Niigata Prefecture, Japan.
Phase of Trial: Phase IV
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Rotavirus vaccine (Primary)
- Indications Rotavirus infections
- Focus Therapeutic Use
- 10 Jan 2018 Planned End Date changed from 31 May 2017 to 31 May 2022.
- 24 Feb 2015 New trial record